細胞毒性藥物的契約製造市場：依生產規模、劑型、產品類型和地區分類。

Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, By Form, By Product Type, By Geography

出版日期: 2026年02月04日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，細胞毒性藥物的契約製造市場規模將達到 126.065 億美元，到 2033 年將達到 231.575 億美元。預計從 2026 年到 2033 年，該市場將以 9.1% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	126.065億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026-2033年預測期間的複合年成長率：	9.10%	2033年市場規模預測：	231.575億美元

過去十年，細胞毒性藥物的契約製造市場顯著成長。癌症發病率的上升以及主要企業擴大採用各種成長策略（例如業務擴張、合作和收購），預計將在預測期內推動市場成長。製藥和生物技術公司致力於細胞毒性藥物和高活性藥物原料藥（HPAPI）的研發，既有自主生產，也有外包給其他製造商。

市場動態

預計癌症發生率的上升將推動預測期內的市場成長。例如，根據美國癌症協會的估計，2017年美國有1,688,780人被診斷出患有癌症，並報告了600,920例癌症死亡病例。

預計在預測期內，核准癌症治療藥物數量的不斷增加將推動全球細胞毒性藥物契約製造市場的成長。例如，2018年10月，Catalent Pharma Solutions公司生產的Verastem Oncology公司的COPIKTRA（Duvelisiv）膠囊獲得了美國食品藥物管理局（FDA）的核准。

此外，製藥公司擴大採用契約製造服務預計將在預測期內推動全球細胞毒性藥物契約製造市場的成長。例如，2018年9月，GB Sciences公司選擇Catalent Pharma Solutions作為其合作夥伴，為其提供用於治療帕金森氏症的專有活性藥物成分（API）的口服給藥系統、製劑開發和臨床規模的口服生產服務。

本次調查的主要特點

本報告對細胞毒性藥物的契約製造市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）的市場規模和複合年成長率。
本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球細胞毒性藥物契約製造市場的主要企業進行了分析：公司概況、財務業績、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析細胞毒性藥物契約製造市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

熱圖分析
市佔率分析
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA（SAFC Pharma）
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- CordenPharma International
- BSP Pharmaceuticals SpA
- Catalent, Inc.
- Albany Molecular Research Inc.（AMRI）
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group

第9章

參考
調查方法

簡介目錄

Product Code: CMI3175

Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at USD 12,606.5 Mn in 2026 and is expected to reach USD 23,157.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 12,606.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.10%	2033 Value Projection:	USD 23,157.5 Mn

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study

This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Market Segmentation

Production Scale Insights (Revenue, USD Mn, 2026 - 2033)
- Industrial scale
- Pilot Scale
- Laboratory Scale
Form Insights (Revenue, USD Mn, 2026 - 2033)
- Liquid
- Solid
Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Oral
- Intravenous
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA (SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- BSP Pharmaceuticals S.p.A.
- CordenPharma Internatisonal
- Catalent, Inc.
- Albany Molecular Research Inc.
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Production Scale
- Market Snippet, By Form
- Market Snippet, By Product Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Epidemiology
Market Trends
Product Launch
Regulatory Scenario
PEST Analysis
Merger and Acquisition Scenario
Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Industrial scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pilot Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Laboratory Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Liquid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Solid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Intravenous
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Lonza Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Piramal Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Evonik Industries AG
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novasep Holding SAS
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck KGaA (SAFC Pharma)
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Baxter Biopharma Solutions
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AbbVie Contract Manufacturing
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Cambrex Corporation
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- CordenPharma International
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BSP Pharmaceuticals S.p.A.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Catalent, Inc.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Albany Molecular Research Inc. (AMRI)
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Evotec
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- WuXi AppTec Co., Ltd.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Pierre Fabre Laboratories
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Dishman Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views